Author:
Gravatt Leigh Anne Hylton,Leibrand Crystal R,Patel Sulay,McRae MaryPeace
Publisher
Springer Science and Business Media LLC
Reference55 articles.
1. WHO. World Health Organization HIV/AIDS Fact Sheet [Internet]. 2017 [cited 2017 Aug 1]. Available from: http://www.who.int/mediacentre/factsheets/fs360/en/
2. CDC. Centers for Disease Control and Prevention HIV Fact Sheet [Internet]. 2017. Available from: https://www.cdc.gov/hiv/library/factsheets/index.html
3. Nettles RE, Schurmann D, Zhu L, Stonier M, Huang SP, Chang I, et al. Pharmacodynamics, safety, and pharmacokinetics of BMS-663068, an oral HIV-1 attachment inhibitor in HIV-1-infected subjects. J Infect Dis. 2012;206:1002–11.
4. Lalezari JP, Latiff GH, Brinson C, Echevarría J, Treviño-Pérez S, Bogner JR, et al. Safety and efficacy of the HIV-1 attachment inhibitor prodrug BMS-663068 in treatment-experienced individuals: 24 week results of AI438011, a phase 2b, randomised controlled trial. Lancet HIV. 2015;2:e427–37.
5. ClinicalTrials.gov. clinicaltrials.gov NCT02362503 [Internet]. 2017 [cited 2017 Jul 23]. Available from: https://clinicaltrials.gov/ct2/show/NCT02362503
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献